RESUMO
Malnutrition may result in a phosphate-deficient state owing to a chronically insufficient phosphate intake. Concomitant iron deficiency is common and often supplemented by the intravenous route. It is not widely recognized that some parenteral iron formulations can induce hypophosphatemia. Herein we report a case of a severe and symptomatic hypophosphatemia (0.18 mM, normal range 0.8-1.4 mM) associated with an inappropriately reduced tubular reabsorption of phosphate (33%, norm >95%) in a malnourished patient with anorexia/bulimia who received 2 × 500 mg iron carboxymaltose (FCM) intravenously. Despite intravenous and oral phosphate supplements, it required 2 months to achieve a normal serum phosphate level. Our case demonstrates that in a chronically malnourished and phosphate-deficient state intravenous FCM could potentially be dangerous. If this form of iron application cannot be avoided, phosphate supplementation before and after iron infusion as well as close monitoring of phosphate levels are needed.
Assuntos
Compostos Férricos/efeitos adversos , Hipofosfatemia/patologia , Desnutrição/tratamento farmacológico , Maltose/análogos & derivados , Administração Oral , Anemia Ferropriva/complicações , Anemia Ferropriva/tratamento farmacológico , Anorexia/complicações , Anorexia/diagnóstico , Anorexia/tratamento farmacológico , Bulimia/complicações , Bulimia/diagnóstico , Bulimia/tratamento farmacológico , Suplementos Nutricionais , Feminino , Compostos Férricos/administração & dosagem , Humanos , Hipofosfatemia/induzido quimicamente , Injeções Intravenosas , Desnutrição/diagnóstico , Desnutrição/etiologia , Maltose/administração & dosagem , Maltose/efeitos adversos , Nutrição Parenteral/efeitos adversos , Fosfatos/administração & dosagem , Redução de Peso , Adulto JovemRESUMO
Nutritional intake is often compromised in elderly, multimorbid patients. Enteral nutrition (EN) by means of oral nutritional supplements (ONS) and tube feeding (TF) offers the possibility to increase or to insure nutrient intake in case of insufficient oral food intake. The present guideline is intended to give evidence-based recommendations for the use of ONS and TF in geriatric patients. It was developed by an interdisciplinary expert group in accordance with officially accepted standards and is based on all relevant publications since 1985. The guideline was discussed and accepted in a consensus conference. EN by means of ONS is recommended for geriatric patients at nutritional risk, in case of multimorbidity and frailty, and following orthopaedic-surgical procedures. In elderly people at risk of undernutrition ONS improve nutritional status and reduce mortality. After orthopaedic-surgery ONS reduce unfavourable outcome. TF is clearly indicated in patients with neurologic dysphagia. In contrast, TF is not indicated in final disease states, including final dementia, and in order to facilitate patient care. Altogether, it is strongly recommended not to wait until severe undernutrition has developed, but to start EN therapy early, as soon as a nutritional risk becomes apparent.